AGI Announces First Quarter 2025 Results and Reiterates Full Year Outlook
First Quarter 2025 Highlights
-
Revenue of
$287 million was down 9% on a year-over-year (“YOY”) basis -
Adjusted EBITDA1 of
$31 million , above the$25-$30 million outlook provided by AGI - Adjusted EBITDA margin %2 of 10.9% was lower on a YOY basis due to a segment mix with a higher weighting of Commercial segment revenue relative to Farm
-
Free cash flow1 of
$41 million on a last twelve months (“LTM”) basis endingMarch 31, 2025 -
Net debt leverage ratio2 of 3.6x at
March 31, 2025 vs 3.1x atDecember 31, 2024 -
Repurchased 224,900 shares for cancellation under the Normal Course Issuer Bid at a cost of
$9 million
2025 Outlook
-
Adjusted EBITDA guidance for the full year 2025 remains consistent with expectations of at least
$225 million 1 -
Adjusted EBITDA guidance for the second quarter of 2025 in the range of
$50-$55 million 1 -
The order book3 up 5% YOY to
$725 million , supported by significant growth within our international Commercial businesses - Commercial segment visibility for full year 2025 revenues is strong, supported by the healthy order book
- Farm segment visibility to the second half of 2025 remains limited due to challenging market conditions
Tariffs
- Current tariff policies exempt USMCA-compliant products which includes AGI’s Canadian-made equipment, though some products are subject to tariffs on Canadian-made steel derivatives
- Based on current policies and regulations, we estimate a relatively minor direct cost impact to AGI in 2025, and it has been factored into our outlook
- Tariff and trade policies could ultimately impact our current financial outlook should they hamper farmer sentiment, aggregate equipment demand, and the global economy more broadly
“Our first quarter results came in slightly above expectations on the strength of our International business,” said
“Our first quarter results highlight the resilience and potential of our business,” added
1 |
Historical or forward-looking non-IFRS financial measure. See “Non-IFRS and Other Financial Measures”.
- First quarter 2025 loss before income taxes of -
- Cash provided by operating activities of
- Adjusted EBITDA for the year ended
- Adjusted EBITDA for the three-month period ended |
2 |
Historical or forward-looking non-IFRS ratio. See “Non-IFRS and Other Financial Measures”. |
3 |
Supplementary financial measure. See "Non-IFRS and Other Financial Measures". |
SUMMARY OF FIRST QUARTER 2025 RESULTS
Revenue by Operating Segment |
Three-months ended |
|||
|
2025 |
2024 |
Change |
Change |
[thousands of dollars except percentages] |
$ |
$ |
$ |
% |
Revenue [1] |
||||
Farm |
95,095 |
188,986 |
(93,891) |
(50%) |
Commercial |
191,651 |
125,610 |
66,041 |
53% |
Total |
286,746 |
314,596 |
(27,850) |
(9%) |
Adjusted EBITDA by Operating Segment |
Three-months ended |
||||
|
2025 |
2024 |
Change |
Change |
|
[thousands of dollars except percentages] |
$ |
$ |
$ |
% |
|
Adjusted EBITDA [2] |
|
|
|
||
Farm |
19,177 |
45,008 |
(25,831) |
(57%) |
|
Commercial |
24,486 |
13,218 |
11,268 |
85% |
|
Other [4] |
(12,398) |
(8,162) |
(4,236) |
N/A |
|
Total |
31,265 |
50,064 |
(18,799) |
(38%) |
|
Adjusted EBITDA Margin % by Operating Segment |
Three-months ended |
||||
|
2025 |
2024 |
Change |
Change |
|
% |
% |
basis points |
% |
||
Adjusted EBITDA Margin % [2] |
|||||
Farm |
20.2% |
23.8% |
(365) bps |
(15%) |
|
Commercial |
12.8% |
10.5% |
225 bps |
21% |
|
Other [3] |
(4.3%) |
(2.6%) |
(173) bps |
N/A |
|
Consolidated |
10.9% |
15.9% |
(501) bps |
(31%) |
|
Revenue by Geography [1] |
Three-months ended |
|||
[thousands of dollars except percentages] |
2025 |
2024 |
Change |
Change |
$ |
$ |
$ |
% |
|
|
34,827 |
78,964 |
(44,137) |
(56%) |
|
107,385 |
148,319 |
(40,934) |
(28%) |
International |
144,534 |
87,313 |
57,221 |
66% |
Total Revenue |
286,746 |
314,596 |
(27,850) |
(9%) |
[1] |
Supplementary financial measure. See "Non-IFRS and Other Financial Measures". |
[2] |
Non-IFRS financial measure or non-IFRS ratio. See "Non-IFRS and Other Financial Measures". |
[3] |
Included in Other is the corporate office, which is not a reportable segment, and which provides finance, treasury, legal, human resources and other administrative support to the segments and geographical regions, as applicable. The Adjusted EBITDA Margin % for Other is calculated based on total revenue since it does not generate revenue without the segments. |
Order book
The following table presents YOY changes in the Company’s order book[1] as at
|
As at |
|||
[thousands of dollars except percentages] |
2025 |
2024[2] |
Change |
Change |
$ |
$ |
$ |
% |
|
Order book |
724,543 |
692,191 |
32,352 |
5% |
[1] |
Supplementary financial measure. See "Non-IFRS and Other Financial Measures". |
[2] |
The order book as at |
First Quarter Farm Segment Summary
Across all geographies, particularly in the
First Quarter Commercial Segment Summary
Commercial segment revenue increased YOY by 53% in the first quarter as we execute several long-term projects across various international businesses.
MD&A and Financial Statements
AGI's unaudited interim condensed consolidated financial statements ("consolidated financial statements") and management’s discussion and analysis (the “MD&A”) for the quarter ended
Conference Call
AGI will hold a conference call on
AGI Company Profile
AGI is a provider of the equipment and solutions required to support the efficient storage, transport, and processing of food globally. AGI has manufacturing facilities in
Further information can be found in the disclosure documents filed by AGI with the securities regulatory authorities, available at www.sedarplus.ca and on AGI's website www.aggrowth.com.
NON-IFRS AND OTHER FINANCIAL MEASURES
This press release makes reference to certain specified financial measures, including non-IFRS financial measures, non-IFRS ratios and supplementary financial measures. Management uses these financial measures for purposes of comparison to prior periods and development of future projections and earnings growth prospects. This information is also used by management to measure the profitability of ongoing operations and in analyzing our business performance and trends. These specified financial measures are not recognized measures under International Financial Reporting Standards (“IFRS”), do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement our financial information reported under IFRS by providing further understanding of our results of operations from management’s perspective. Accordingly, they should not be considered in isolation nor as a substitute for analysis of our financial information reported under IFRS.
We use the following (i) non-IFRS financial measures: “adjusted earnings before interest, taxes, depreciation, and amortization (“Adjusted EBITDA”)”, “free cash flow” and “net debt”; (ii) non-IFRS ratios: “Adjusted EBITDA margin %” and “net debt leverage ratio”; and (iii) supplementary financial measures: “order book”, “revenue by operating segment” and “revenue by geography”; to provide supplemental measures of our operating performance and thus highlight trends in our core business that may not otherwise be apparent when relying solely on IFRS financial measures. Management also uses non-IFRS financial measures, non-IFRS ratios and supplementary financial measures in order to prepare annual operating budgets and to determine components of management compensation. We strongly encourage investors to review our consolidated financial statements and publicly filed reports in their entirety and not to rely on any single financial measure or ratio.
We use these specified financial measures in addition to, and in conjunction with, results presented in accordance with IFRS. These specified financial measures reflect an additional way of viewing aspects of our operations that, when viewed with our IFRS results and, in the case of non-IFRS financial measures, the accompanying reconciliations to the most directly comparable IFRS financial measures, may provide a more complete understanding of factors and trends affecting our business.
In this press release, we discuss the specified financial measures, including the reasons that we believe that these measures provide useful information regarding our financial condition, results of operations, cash flows and financial position, as applicable, and, to the extent material, the additional purposes, if any, for which these measures are used. Reconciliations of non-IFRS financial measures to the most directly comparable IFRS financial measures are contained in this press release.
The following is a list of non-IFRS financial measures, non-IFRS ratios and supplementary financial measures that are referenced throughout this press release:
“Adjusted EBITDA” is defined as profit (loss) before income taxes before finance costs, depreciation and amortization, share of associate’s net profit, gain or loss on foreign exchange, non-cash share-based compensation expenses, net gain or loss on financial instruments, transaction, transitional and other costs,
“Adjusted EBITDA margin %” is defined as Adjusted EBITDA divided by revenue. Adjusted EBITDA margin % is a non-IFRS ratio because one of its components, Adjusted EBITDA, is a non-IFRS financial measure. Management believes Adjusted EBITDA margin % is a useful measure to assess the performance and cash flow of the Company.
“Free cash flow” is defined as cash provided by operating activities less acquisition of property, plant and equipment and less development and purchase of intangible assets. Free cash flow is a non-IFRS financial measure and its most directly comparable financial measure that is disclosed in our consolidated financial statements is cash provided by operating activities. Management believes that free cash flow provides useful information about the Company’s ability to generate available cash that can be used to fund ongoing and prospective strategic initiatives, reduce debt, or pursue other initiatives to enhance shareholder value after investing in capital expenditures that are required to maintain and grow the Company. Management uses free cash flow to help monitor the operational efficiency and financial flexibility of the Company. See “Free Cash Flow” below for a reconciliation of free cash flow to cash provided by operating activities for the current and comparative LTM periods.
“Order book” is defined as the total value of committed sales orders that have not yet been fulfilled that: (a) have a high certainty of being performed as a result of the existence of a purchase order, an executed contract or work order specifying job scope, value and timing; or (b) has been awarded to the Company or its divisions, as evidenced by an executed binding letter of intent or agreement, describing the general job scope, value and timing of such work, and where the finalization of a formal contract in respect of such work is reasonably assured. Order book is a supplementary financial measure.
“Revenue by Operating Segment” and “Revenue by Geography”: The revenue information presented under “Revenue by Operating Segment” and “Revenue by Geography” are supplementary financial measures used to present the Company’s revenue by segment and geography.
“Net Debt Leverage Ratio” is a non-IFRS ratio and is defined as net debt divided by Adjusted EBITDA for the last twelve-month (“LTM”) period. Net debt leverage ratio is a non-IFRS ratio because its components, net debt and Adjusted EBITDA, are non-IFRS financial measures. Management believes net debt leverage ratio is a useful measure to assess AGI’s leverage position.
“Net Debt” is a non-IFRS financial measure and its most directly comparable financial measure that is disclosed in our consolidated financial statements is long-term debt. Net debt is defined as the sum of long-term debt, convertible unsecured subordinated debentures, senior unsecured subordinated debentures, and lease liabilities less cash and cash equivalents. Management believes that net debt is a useful measure to evaluate AGI’s capital structure and to provide a measurement of AGI’s total indebtedness. See “Net Debt” below for a reconciliation of long-term debt to net debt.
Profit (loss) before income taxes and Adjusted EBITDA
The following table reconciles profit (loss) before income taxes to Adjusted EBITDA.
|
Year ended |
|
|
||
[thousands of dollars] |
2024 |
2023 |
$ |
$ |
|
Profit (loss) before income taxes |
(5,326) |
86,067 |
Finance costs |
70,242 |
73,667 |
Depreciation and amortization |
70,798 |
65,316 |
Share of associate's net profit [1] |
(109) |
— |
Loss (gain) on foreign exchange [2] |
43,119 |
(7,571) |
Share-based compensation [3] |
13,758 |
12,159 |
Net gain on financial instruments [4] |
(3,812) |
(5,369) |
Transaction, transitional and other costs [5] |
56,148 |
27,174 |
|
17,271 |
14,001 |
Net loss on sale of long-lived assets [7] |
23 |
454 |
Equipment rework and remediation |
— |
24,108 |
Accounts receivable reserve (recovery) for RUK |
(268) |
1,651 |
Impairment charge [8] |
2,944 |
2,237 |
Adjusted EBITDA [9] |
264,788 |
293,894 |
[1] |
See “Note 7 – |
[2] |
See “Note 25[e] – Finance expenses (income)” in our 2024 consolidated financial statements. |
[3] |
The Company’s share-based compensation expense pertains to our equity incentive award plan (“EIAP”) and directors’ deferred compensation plan (“DDCP”). See “Note 24 – Share-based compensation plans” in our 2024 consolidated financial statements. |
[4] |
See “Equity swap” in “Note 30 – Financial instruments and financial risk management” in our 2024 consolidated financial statements. |
[5] |
Includes legal expense, legal provision, transitional costs related to reorganizations and other acquisition related transition costs, as well as the accretion and other movement in amounts due to vendors. |
[6] |
Expenses incurred in connection with a global multi-year ERP transformation project. |
[7] |
See “Note 11 – Property, plant and equipment” and “Note 16 – Assets held for sale” in our 2024 consolidated financial statements. |
[8] |
See “Impairment charge” in our 2024 consolidated financial statements. |
[9] |
This is a non-IFRS measure and is used throughout this press release. See “NON-IFRS AND OTHER FINANCIAL MEASURES” for more information on each non-IFRS measure. |
|
Three-months ended |
|
|
||
[thousands of dollars] |
2025 |
2024 |
$ |
$ |
|
Profit (loss) before income taxes |
(16,571) |
3,849 |
Finance costs |
16,593 |
18,951 |
Depreciation and amortization |
17,259 |
17,145 |
Share of associate’s net loss [1] |
142 |
— |
Loss (gain) on foreign exchange [2] |
(1,193) |
5,418 |
Share-based compensation [3] |
2,002 |
4,416 |
Net loss (gain) on financial instruments [4] |
6,607 |
(7,816) |
Transaction, transitional and other costs [5] |
3,717 |
4,450 |
ERP system transformation costs [6] |
2,797 |
4,125 |
Net gain on sale of long-lived assets [7] |
(8) |
(206) |
Accounts receivable recovery for RUK |
— |
(268) |
Impairment recovery |
(80) |
— |
Adjusted EBITDA [8] |
31,265 |
50,064 |
[1] |
See “Note 6 – |
[2] |
See “Note 12[e] – Finance expense (income)” in our consolidated financial statements. |
[3] |
The Company’s share-based compensation expense pertains to our equity incentive award plan (“EIAP”) and directors’ deferred compensation plan (“DDCP”). See “Note 11 – Share-based compensation plans” in our consolidated financial statements. |
[4] |
See “Equity swap” in “Note 16 – Financial instruments and financial risk management” in our consolidated financial statements. |
[5] |
Includes legal expense, legal provision, transitional costs related to reorganizations and other acquisition related transition costs, as well as the accretion and other movement in amounts due to vendors. |
[6] |
Expenses incurred in connection with a global multi-year ERP transformation project. |
[7] |
Includes gain/loss on sale of property, plant, equipment, assets held for sale, and settlement of lease liabilities. |
[8] |
This is a non-IFRS measure and is used throughout this press release. See “NON-IFRS AND OTHER FINANCIAL MEASURES” for more information on each non-IFRS measure. |
|
Three-months ended |
|
|
||
[thousands of dollars] |
2024 |
2023 |
$ |
$ |
|
Profit (loss) before income taxes |
(7,650) |
18,068 |
Finance costs |
17,060 |
18,337 |
Depreciation and amortization |
18,306 |
16,431 |
Loss (gain) on foreign exchange [1] |
13,791 |
(6,533) |
Share-based compensation [2] |
2,768 |
2,038 |
Loss on financial instruments [3] |
3,812 |
8,184 |
Transaction, transitional and other costs [4] |
11,929 |
8,795 |
ERP system transformation costs [5] |
4,925 |
— |
Net loss on disposal of property, plant and equipment |
198 |
19 |
Net gain on settlement of lease liability |
(188) |
(7) |
Equipment rework [6] |
— |
4,900 |
Remediation [6] |
— |
15,608 |
Accounts receivable reserve for RUK |
— |
1,733 |
Impairment charge [7] |
3,091 |
601 |
Adjusted EBITDA [8] |
68,042 |
88,174 |
[1] |
See “Note 13[e] – Finance expenses (income)” in our unaudited interim condensed consolidated financial statements for the three- and six-month periods ended |
[2] |
The Company’s share-based compensation expense pertains to our equity incentive award plan (“EIAP”) and directors’ deferred compensation plan (“DDCP”). See “Note 12 – Share-based compensation plans” in our 2024 Q2 consolidated financial statements. |
[3] |
See “Equity swap” in “Note 17 – Financial instruments and financial risk management” in our 2024 Q2 consolidated financial statements. |
[4] |
Includes legal expense, legal provision, transitional costs related to reorganizations and other acquisition related transition costs, as well as the accretion and other movement in amounts due to vendors. |
[5] |
Expenses incurred in connection with a global multi-year ERP transformation project. |
[6] |
See “Remediation costs” and “Equipment rework” in “Note 9 – Provisions” in our 2024 Q2 consolidated financial statements. |
[7] |
See “Note 8 – Impairment charge” in our 2024 Q2 consolidated financial statements. |
[8] |
This is a non-IFRS measure and is used throughout this press release. See “NON-IFRS AND OTHER FINANCIAL MEASURES” for more information on each non-IFRS measure. |
|
Three-months ended |
|
|
||
[thousands of dollars] |
2024 |
2023 |
$ |
$ |
|
Profit before income taxes |
3,849 |
21,626 |
Finance costs |
18,951 |
17,681 |
Depreciation and amortization |
17,145 |
16,040 |
Loss (gain) on foreign exchange [1] |
5,418 |
(2,617) |
Share-based compensation [2] |
4,416 |
4,268 |
Gain on financial instruments [3] |
(7,816) |
(13,204) |
Transaction, transitional and other costs [4] |
4,450 |
3,929 |
ERP system transformation costs [5] |
4,125 |
— |
Net loss (gain) on sale of long-lived assets [6] |
(206) |
199 |
Accounts receivable recovery for RUK |
(268) |
— |
Impairment charge [7] |
— |
190 |
Adjusted EBITDA [8] |
50,064 |
48,112 |
[1] |
See “Note 11[e] – Finance expenses (income)” in our unaudited interim condensed consolidated financial statements for the three-month periods ended |
[2] |
The Company’s share-based compensation expense pertains to our equity incentive award plan (“EIAP”) and directors’ deferred compensation plan (“DDCP”). See “Note 10 – Share-based compensation plans” in our 2024 Q1 consolidated financial statements. |
[3] |
See “Equity swap” in “Note 15 – Financial instruments and financial risk management” in our 2024 Q1 consolidated financial statements. |
[4] |
Includes legal expense, legal provision, transitional costs related to reorganizations and other acquisition related transition costs, as well as the accretion and other movement in amounts due to vendors. |
[5] |
Expenses incurred in connection with a global multi-year ERP transformation project. |
[6] |
See “Note 6 – Assets held for sale” in our 2024 Q1 consolidated financial statements. |
[7] |
Impairment charge related to assets held for sale. See “Note 6 – Assets held for sale” in our 2024 Q1 consolidated financial statements. |
[8] |
This is a non-IFRS measure and is used throughout this press release. See “NON-IFRS AND OTHER FINANCIAL MEASURES” for more information on each non-IFRS measure. |
|
Last Twelve-months ended |
|
|
||
[thousands of dollars] |
2025 |
2024 |
$ |
$ |
|
Profit (loss) before income taxes |
(25,746) |
68,290 |
Finance costs |
67,884 |
74,937 |
Depreciation and amortization |
70,912 |
66,421 |
Share of associate’s net loss [1] |
33 |
— |
Loss on foreign exchange [2] |
36,508 |
464 |
Share-based compensation [3] |
11,344 |
12,307 |
Net loss on financial instruments [4] |
10,611 |
19 |
Transaction, transitional and other costs [5] |
55,415 |
27,695 |
ERP system transformation costs [6] |
15,943 |
18,126 |
Net loss on sale of long-lived assets [7] |
221 |
49 |
Remediation and rework |
— |
24,108 |
Accounts receivable reserve for RUK |
— |
1,383 |
Impairment charge [8] |
2,864 |
2,047 |
Adjusted EBITDA [9] |
245,989 |
295,846 |
[1] |
See “Brazil Investments” in our unaudited interim condensed consolidated financial statements for the three-month period ended |
[2] |
See “Finance expenses (income)” in our 2025 Q1 consolidated financial statements, 2024 and 2023 consolidated financial statements. |
[3] |
The Company’s share-based compensation expense pertains to our equity incentive award plan (“EIAP”) and directors’ deferred compensation plan (“DDCP”). See “Share-based compensation plans” in our 2025 Q1 consolidated financial statements, 2024 and 2023 consolidated financial statements. |
[4] |
See “Equity swap” in our 2025 Q1 consolidated financial statements, 2024 and 2023 consolidated financial statements. |
[5] |
Transaction costs associated with completed and ongoing mergers and acquisitions activities. |
[6] |
Expenses incurred in connection with a global multi-year ERP transformation project. |
[7] |
Includes gain/loss on sale of property, plant, equipment, assets held for sale, and settlement of lease liabilities. See “Property, plant and equipment” and “Assets held for sale” in our 2024 and 2023 consolidated financial statements. |
[8] |
See “Impairment charge” in our 2024 and 2023 consolidated financial statements. |
[9] |
This is a non-IFRS measure and is used throughout this press release. See “NON-IFRS AND OTHER FINANCIAL MEASURES” for more information on each non-IFRS measure. |
Profit (loss) before income taxes and Adjusted EBITDA by Operating Segment
The following tables reconcile profit (loss) before income taxes to Adjusted EBITDA by operating segment for the applicable periods.
|
Three-months ended |
|||
[thousands of dollars] |
Farm |
Commercial |
Other [10] |
Total |
$ |
$ |
$ |
$ |
|
Profit (loss) before income taxes |
10,555 |
16,492 |
(43,618) |
(16,571) |
Finance costs |
— |
— |
16,593 |
16,593 |
Depreciation and amortization [1] |
7,506 |
7,865 |
1,888 |
17,259 |
Share of associate’s net loss [2] |
— |
142 |
— |
142 |
Gain on foreign exchange [3] |
— |
— |
(1,193) |
(1,193) |
Share-based compensation [4] |
— |
— |
2,002 |
2,002 |
Net loss on financial instruments [5] |
— |
— |
6,607 |
6,607 |
Transaction, transitional and other costs [6] |
1,179 |
— |
2,538 |
3,717 |
ERP system transformation costs [7] |
— |
— |
2,797 |
2,797 |
Net loss (gain) on sale of long-lived assets [1] [8] |
17 |
(13) |
(12) |
(8) |
Impairment recovery |
(80) |
— |
— |
(80) |
Adjusted EBITDA [9] |
19,177 |
24,486 |
(12,398) |
31,265 |
|
Three-months ended |
|||
[thousands of dollars] |
Farm |
Commercial |
Other [10] |
Total |
$ |
$ |
$ |
$ |
|
Profit (loss) before income taxes |
38,258 |
5,154 |
(39,563) |
3,849 |
Finance costs |
— |
— |
18,951 |
18,951 |
Depreciation and amortization [1] |
6,964 |
8,326 |
1,855 |
17,145 |
Loss on foreign exchange [3] |
— |
— |
5,418 |
5,418 |
Share-based compensation [4] |
— |
— |
4,416 |
4,416 |
Net gain on financial instruments [5] |
— |
— |
(7,816) |
(7,816) |
Transaction, transitional and other costs [6] |
— |
— |
4,450 |
4,450 |
ERP system transformation costs [7] |
— |
— |
4,125 |
4,125 |
Net loss (gain) on sale of long-lived assets [1] [8] |
(214) |
6 |
2 |
(206) |
Accounts receivable recovery for RUK |
— |
(268) |
— |
(268) |
Adjusted EBITDA [9] |
45,008 |
13,218 |
(8,162) |
50,064 |
[1] |
Allocated based on the segment of the underlying asset’s cash generating unit (“CGU”). |
[2] |
See “Note 6 – |
[3] |
See “Note 12[e] – Finance expense (income)” in our consolidated financial statements. |
[4] |
The Company’s share-based compensation expense pertains to our EIAP and DDCP. See “Note 11 – Share-based compensation plans” in our consolidated financial statements. |
[5] |
See “Equity swap” in “Note 16 – Financial instruments and financial risk management” in our consolidated financial statements. |
[6] |
Includes legal expense, legal provision, transitional costs related to reorganizations and other acquisition related transition costs, as well as the accretion and other movement in amounts due to vendors. |
[7] |
Expenses incurred in connection with a global multi-year ERP transformation project. |
[8] |
Includes gain/loss on sale of property, plant, equipment, assets held for sale, and settlement of lease liabilities. |
[9] |
This is a non-IFRS measure and is used throughout this press release. See “NON-IFRS AND OTHER FINANCIAL MEASURES” for more information on each non-IFRS measure. |
[10] |
Included in Other is the corporate office, which is not a reportable segment, and which provides finance, treasury, legal, human resources and other administrative support to the segments. |
Net Debt
The following table reconciles long term debt to net debt as at
Q1/25 |
Q4/24 |
Q1/24 |
|
[thousands of dollars] |
|
|
|
|
|
||
Long Term Debt |
639,896 |
565,893 |
450,060 |
Convertible Unsecured Subordinated Debentures |
198,837 |
197,019 |
191,756 |
Senior Unsecured Subordinated Debentures |
84,085 |
83,965 |
255,278 |
Leases |
46,705 |
48,279 |
43,361 |
Less: Cash & Cash Equivalents |
76,951 |
79,893 |
89,311 |
Net Debt |
892,572 |
815,263 |
851,144 |
Free Cash Flow
The following table reconciles cash provided by operating activities to free cash flow for the applicable periods.
|
Last Twelve-months ended |
||
[thousands of dollars except percentages] |
|||
2025 |
2024 |
||
$ |
$ |
||
Cash provided by operating activities |
73,412 |
100,149 |
|
Less: acquisition of property, plant and equipment |
(23,479) |
(39,906) |
|
Less: development and purchase of intangibles |
(8,718) |
(9,944) |
|
Free cash flow [1] |
41,215 |
50,299 |
[1] |
This is a non-IFRS measure and is used throughout this press release. See “NON-IFRS AND OTHER FINANCIAL MEASURES” for more information on each non-IFRS measure |
FORWARD-LOOKING INFORMATION
This press release contains forward-looking statements and information [collectively, “forward-looking information”] within the meaning of applicable securities laws that reflect our expectations regarding the future growth, results of operations, performance, business prospects, and opportunities of the Company. All information and statements contained herein that are not clearly historical in nature constitute forward-looking information, and the words “anticipate”, “estimate”, “believe”, “continue”, “could”, “expects”, “intend”, “trend”, “plans”, “will”, “may” or similar expressions suggesting future conditions or events or the negative of these terms are generally intended to identify forward-looking information. Forward-looking information involves known or unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. In addition, this press release may contain forward-looking information attributed to third party industry sources. Undue reliance should not be placed on forward-looking information, as there can be no assurance that the plans, intentions or expectations upon which it is based will occur. In particular, the forward-looking information in this press release includes information relating to: our Adjusted EBITDA guidance for full year 2025; our Adjusted EBITDA guidance for Q2 2025; that our Commercial segment visibility for full year 2025 revenues is strong; our expectations with respect to our Farm segment, including that visibility to the second half of 2025 remains limited due to challenging market conditions, that the timing of a return to a more normalized demand environment for the
Such forward-looking information reflects our current beliefs and is based on information currently available to us, including certain key expectations and assumptions concerning: the duration and impact of tariffs that are currently in effect on goods exported from or imported into
Forward-looking information involves significant risks and uncertainties. A number of factors could cause actual results to differ materially from results discussed in the forward-looking information. These risks and uncertainties include but are not limited to the following: the risk that (i) the tariffs that are currently in effect on goods exported from or imported into
FINANCIAL OUTLOOK
Also included in this press release are estimates of AGI’s Q2 and full-year 2025 Adjusted EBITDA and the potential impact that the tariffs imposed by the
View source version on businesswire.com: https://www.businesswire.com/news/home/20250502289401/en/
Sr. Director, Investor Relations
+1-437-335-1630
investor-relations@aggrowth.com
Source: